- 2021.4.20
- Patents, Articles & Conferences Patent “Method for stabilizing DNA aptamer” is granted in EU.
- 2021.3.22
- News Release Prof. Shinsuke Sando at THE UNIVERSITY OF TOKYO and TAGCyx ANNOUNCES THE RESEARCH COLLABORATION of THE TECHNOLOGICAL IMPROVEMENT OF XENOLIGO®
- 2021.3.5
- News Release TAGCyx announces execution of worldwide exclusive supply of proprietary artificial Ds amidite and patent license agreement with Otsuka Chemical Co., Ltd.
- 2021.2.19
- News Release Prof. Taiichi Sakamoto at CHIBA INSTITUTE TECHNOLOGY and TAGCyx ANNOUNCES THE RESEARCH COLLABORATION of THE STRUCTURAL ANALYSIS OF XENOLIGO®
- 2020.11.29
- Patents, Articles & Conferences Our collaborator, Ms. Yuri Hayata of Prof. Sando Lab (The University of Tokyo) obtained poster award at the Chemical Society of Japan, CSJ Chemistry Festa 2020
- 2020.11.25
- News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES THE RESEARCH AND DEVELOPMENT COLLABORATION OF INOVATIVE CANCER THERAPY
- 2020.11.17
- News Release Showa Denko Materials and the Drug Development Startup TAGCyx Sign a Commissioned Development Agreement on Regenerative Medicine Technologies
- 2020.10.17
- Patents, Articles & Conferences Patent “DNA aptamer capable of bonding to VWF” is granted in the USA.
- 2020.9.25
- Patents, Articles & Conferences Ms. Yukari Ikeda received the Seven Star Pharmacist candidate Award for the results of skin penetration of our anti-IFNγ aptamer.
- 2020.9.18
- News Release TAGCyx announces a research collaboration with CAGE Bio Inc. for autoimmune skin diseases.
- 2020.9.4
- Patents, Articles & Conferences Results of collaboration project with Prof. Sando Lab (The University of Tokyo) will be presented at the Chemical Society of Japan, CSJ Chemistry Festa 2020
- 2020.9.3
- Patents, Articles & Conferences Patent “Method for stabilizing functional nucleic acids” is granted in Europe.